During infection, antibody responses are one of the important hostdefense mechanisms used to clear invading pathogens. Antibodies produced by B cells mediate the destruction of extracellular microorganisms and prevent the spread of intracellular infectious agents. The activation of naive B cells is triggered by antigen and usually requires follicular helper T cells (T FH cells) for sustained proliferation and differentiation 1,2 . Germinal centers (GCs) are transient structures in the B cell follicles of secondary lymphoid tissues in which B cells undergo somatic hypermutation, affinity maturation and differentiation into memory B cells and long-lived plasma cells 3 . The formation of GCs is controlled by T FH cells, which are required for the initial help provided to B cells as well as for the maintenance of GCs by positive selection of B cells expressing B cell antigen receptors (BCRs) of the highest affinity. T FH cells also regulate the generation of plasma cells and memory B cells. T FH cells localize in the follicles and GCs because their expression of a set of genes encoding migration-related molecules, most notably the chemokine receptor CXCR5, is different from that of other helper T cells.
During infection, antibody responses are one of the important hostdefense mechanisms used to clear invading pathogens. Antibodies produced by B cells mediate the destruction of extracellular microorganisms and prevent the spread of intracellular infectious agents. The activation of naive B cells is triggered by antigen and usually requires follicular helper T cells (T FH cells) for sustained proliferation and differentiation 1, 2 . Germinal centers (GCs) are transient structures in the B cell follicles of secondary lymphoid tissues in which B cells undergo somatic hypermutation, affinity maturation and differentiation into memory B cells and long-lived plasma cells 3 . The formation of GCs is controlled by T FH cells, which are required for the initial help provided to B cells as well as for the maintenance of GCs by positive selection of B cells expressing B cell antigen receptors (BCRs) of the highest affinity. T FH cells also regulate the generation of plasma cells and memory B cells. T FH cells localize in the follicles and GCs because their expression of a set of genes encoding migration-related molecules, most notably the chemokine receptor CXCR5, is different from that of other helper T cells.
T FH cells express interleukin 21 (IL-21), IL-4 and the chemokine CXCL13 and are characterized by high expression of surface markers required for cognate T cell-B cell interactions, including CXCR5, the inducible costimulator ICOS, the T cell inhibitory receptor PD-1, the ligand for the costimulatory receptor CD40 and members of the SLAM family of receptors 1 . Three independent groups have identified the transcription repressor Bcl-6, a member of the BTB-POZ ('bric-a-bric, tramtrack, broad complex-poxvirus zinc finger') family of zinc-finger-containing transcription factors, as a master transcription factor for T FH cells [4] [5] [6] . These results clearly established T FH cells as a subset distinct from other T H cell subsets. However, the regulation of the differentiation of T FH cells is only partially characterized.
Accumulating evidences suggests that several cytokines, including IL-6 and IL-21, contribute to the differentiation of T FH cells through mechanisms dependent on the transcription factors STAT3 and STAT1 (refs. 7-12) . Signaling via ICOS and its ligand is required for Bcl-6 expression and the differentiation of T FH cells 13, 14 and is important for the migration of T FH cells 15 . In contrast, signaling via IL-2 potently inhibits the differentiation of T FH cells by mechanisms dependent on the transcription factors STAT5 and Blimp-1 (refs. [16] [17] [18] . Blimp-1 is a powerful repressor of Bcl-6 expression 4 . However, details of the mechanisms by which Bcl-6 expression is induced and Bcl-6 is regulated are not well understood 19 , nor are the interactions between Bcl-6 and other key transcription factors involved in the differentiation of T FH cells, including c-Maf, BATF, IRF4 and others 13, [20] [21] [22] .
The ubiquitination of proteins is a post-translational modification in which a protein substrate is 'tagged' with the 76-amino acid small polypeptide ubiquitin as mono-or poly-ubiquitin chains, an event catalyzed by a cascade of enzymes, including E1, E2 and E3 (ref. 23 ). The modified proteins can be subjected to proteasomal degradation or endocytosis, or the ubiquitin modification can instead alter protein function, analogous to phosphorylation or acetylation. Ubiquitin ligases are critical regulators of many biological processes 23 . In T cells, ubiquitin ligases control signaling via the T cell antigen receptor 24 , anergy 25 , differentiation into T helper type 2 (T H 2) cells 26 , differentiation into regulatory T cells 27 and other processes. On the basis of the structural features of their E2-binding domain, most E3 ligases can be classified into two families: RING ('really interesting new gene')-type E3 ligases, and HECT ('homologous to the E6-associated protein carboxyl terminus')-type E3 ligases 28 . Itch belongs to the HECT family of E3 ligases. The locus encoding Itch is disrupted by an inversion in mice of the itchy strain, which develop severe immunological and A r t i c l e s inflammatory disorders and constant itching of the skin 29 . Itch targets the transcription factors JunB and c-Jun for degradation and inhibits the production of T H 2 cell cytokines 26 . In this study, we present evidence of a critical role for Itch in the differentiation of T FH cells. Itchdeficient mice underwent a decrease in the abundance of GC B cells and antigen-specific antibody production after viral infection, due to a cell-intrinsic defect in T FH cell differentiation. This defect in T FH cell differentiation was not associated with T H 2 cells and was independent of signaling via IL-2. Enforced expression of Bcl-6 restored the T FH differentiation of Itch −/− T cells, which suggested that Itch functioned upstream of Bcl-6. Unexpectedly, the defective T FH cell differentiation was rectified by ablation of the gene encoding the transcription factor Foxo1. We further demonstrated that Itch associated with Foxo1 and promoted its ubiquitination and subsequent degradation. Our data suggest that Itch is essential for inducing the differentiation of T FH cells and humoral immunity by targeting Foxo1 for degradation.
RESULTS T FH cell differentiation requires Itch
To investigate the role of E3 ubiquitin ligases in T FH cell differentiation and humoral immune responses, we did a small-scale screen of mice deficient in genes encoding E3 ligases known to be expressed in CD4 + T cells, including Itch, Cblb, Cbl and Wwp2, in a model of infection with vaccinia virus (VACV) 14 . At day 8 after infection, we analyzed T cell and B cell responses by flow cytometry and measured virus-specific antibody responses by enzyme-linked immunosorbent assay (ELISA). Mice of the itchy strain (called 'Itch −/− mice' here) exhibited a significantly lower frequency and absolute number of both T FH cells (CXCR5 + SLAM lo ) and GC T FH cells (CXCR5 + PD-1 hi or CXCR5 + Bcl-6 hi ) than that of wild-type mice (Fig. 1a,b) . We observed the considerably defective T FH cell phenotype in Itch −/− mice but not in mice with other ubiquitin-ligase deficiencies ( Supplementary  Fig. 1a-c) , which indicated a selective role for Itch in the differentiation of T FH cells. To further explore such differentiation in Itch −/− mice, we isolated activated CD4 + T cells from VACV-infected wild-type and Itch −/− mice and analyzed their T FH cell-related gene-expression profiles by real-time quantitative PCR. The expression of T FH cell-related genes, including Cxcr5, Icos, Bcl6 and IL21, was lower in activated Itch −/− CD4 + T cells than in their wild-type counterparts (Supplementary Fig. 1d ). Il4 expression was higher in activated Itch −/− CD4 + T cells than in their wild-type counterparts ( Supplementary Fig. 1d ), consistent with a published report 26 .
Because T FH cells are the main cognate helpers of antiviral B cell responses 4 , we next examined GC formation in Itch −/− mice after infection with VACV. As expected, we observed a robust abundance of GC B cells in wild-type C57BL/6J (B6) mice after infection with VACV, but the frequency and absolute number of GC B cells were much lower in their Itch −/− counterparts after such infection (Fig. 1c,d and Supplementary Fig. 1e ). We then assessed differentiation into plasma cells in wild-type and Itch −/− mice after infection with VACV. Consistent with the lower abundance of GC B cells, the number of plasma cells was also much lower in Itch −/− mice (Fig. 1c,d) . To assess the consequences of the defective T FH cell and GC B cell responses of Itch −/− mice, we measured VACV-specific serum concentrations of immunoglobulin G (IgG). VACV-specific IgG concentrations were 57-fold lower the serum of Itch −/− mice than in that of wild-type mice ( Fig. 1e and Supplementary Fig. 1f) . Collectively, these data suggested that Itch was required for the generation of T FH cells, GC B cells and high-affinity antibodies.
We next investigated whether Itch deficiency affected the production of inflammatory cytokines and type I interferons during acute viral infection, which could possibly result in enhanced clearance of the infecting virus and indirectly diminish the abundance of T FH cells. We collected serum from wild-type and Itch −/− mice at days 1, 2 and 8 after infection with VACV and measured the concentration of inflammatory cytokines (for example, IL-6) and type I interferons in the sera. We observed no substantial differences between wild-type mice and Itch −/− mice ( Supplementary Fig. 1g and data not shown). Furthermore, there was no significant difference in viral load in spleens from wild-type and Itch −/− mice 4 d after viral infection (P = 0.87; Supplementary Fig. 1h ). These data suggested that any differences between Itch −/− mice and wild-type mice in their innate immune responses did not have much influence on the defective differentiation of T FH cells.
Intrinsic regulation of T FH cell differentiation by Itch
Next we investigated whether Itch regulates T FH cell differentiation in T cell-dependent manner. To address this issue, we crossed mice with a loxP-flanked Itch exon (Itch fl/fl ) 30 with mice carrying a transgene encoding Cre recombinase under the control of the Cd4 enhancer-promoter (CD4-Cre) to generate mice with T cell-specific (conditional) Itch deficiency (Itch-cKO). We then analyzed the T cell and B cell responses of Itch-cKO mice after infection with VACV. Similar to Itch −/− mice, Itch-cKO mice had a much lower frequency and absolute number of both T FH cells (CXCR5 + SLAM lo ) and GC T FH cells (CXCR5 + PD-1 hi or CXCR5 + Bcl-6 hi ) than did their wildtype counterparts (Fig. 1f,g ). Moreover, the frequency and number of GC B cells were much lower in Itch-cKO mice than in wild-type mice (Fig. 1h,i and Supplementary Fig. 1i) . Furthermore, the generation of plasma cells was also significantly lower in Itch-cKO mice than in wild-type mice (Fig. 1h,i) . Finally, VACV-specific IgG concentrations were 41-fold lower in the serum of Itch-cKO mice than in that of wild-type mice ( Fig. 1j and Supplementary Fig. 1j ). The similar phenotypes of Itch −/− mice and Itch-cKO mice suggested that Itch regulated T FH cell differentiation and humoral immunity in a T cell-intrinsic manner.
Itch in various stages of T FH cell differentiation T FH cell differentiation is a multistage, multifactorial process 1 .
To investigate at what phases Itch regulates such differentiation, we crossed Itch −/− mice with SMARTA mice (which have transgenic expression of a T cell antigen receptor specific for the epitope of lymphocytic choriomeningitis virus (LCMV) glycoprotein amino acids 66-77, presented by the major histocompatibility complex (MHC) class II molecule I-A b ) to generate Itch −/− SMARTA mice 31 . We isolated naive CD4 + T cells from Itch +/+ SMARTA mice (called 'wildtype SMARTA mice' here) and Itch −/− SMARTA mice and then adoptively transferred them separately into B6 recipient mice, followed by subsequent acute infection of the host mice with LCMV. Although Itch −/− SMARTA CD4 + T cells showed normal proliferation (Supplementary Fig. 2a) , they almost completely failed to differentiate into T FH cells by day 3 after infection, as measured by gating of CXCR5 + SLAM lo , CXCR5 + PD-1 hi or CXCR5 + Bcl-6 hi cells (Fig. 2a,b) . Moreover, expression of both CXCR5 protein (P = 0.0012) and Bcl-6 protein (P = 0.0046) was significantly lower in Itch −/− SMARTA CD4 + T cells than in wild-type SMARTA CD4 + T cells ( Supplementary  Fig. 2b) . Consistent with that, Itch −/− SMARTA CD4 + T cells had lower levels of Cxcr5, Bcl6 and Il21 mRNA and higher levels of Prdm1 mRNA (which encodes Blimp-1) at day 3 after infection ( Fig. 2c) . These results suggested that the defective T FH differentiation of Itch −/− cells was associated with a failure to express Bcl-6 at early time points.
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As ICOS is required for Bcl-6 expression at day 3 after infection in vivo 14 , we quantified Icos expression in wild-type and Itch −/− SMARTA CD4 + T cells. Although Itch −/− SMARTA CD4 + T cells failed to differentiate into T FH cells, their expression of Icos mRNA and ICOS protein was similar to that of wild-type SMARTA CD4 + T cells ( Fig. 2c and Supplementary Fig. 2c) . Moreover, the expression of genes encoding some transcription factors upstream of Bcl-6, such as Batf and Irf4, was also intact in Itch −/− SMARTA CD4 + T cells (Fig. 2c) . These results indicated that the defective differentiation of Itch −/− T FH cells was not due to changes in the expression of ICOS or known transcription factors upstream of Bcl-6.
We next investigated whether the early defect in Itch −/− T FH cells continued through the peak of the LCMV-specific response (day 8) and whether it affected GC T FH cell development. Itch −/− SMARTA CD4 + T cells showed normal proliferation at day 8 after infection with LCMV (Supplementary Fig. 2d ). Notably, we observed an almost complete loss of T FH cells among Itch −/− SMARTA CD4 + T cells (Fig. 2d,e ). There were almost no GC T FH cells (CXCR5 + PD-1 hi , CXCR5 + Bcl-6 hi or CXCR5 + GL7 hi ) among Itch −/− SMARTA CD4 + T cells (Fig. 2d,e and Supplementary Fig. 2e ). In addition, Itch −/− SMARTA CD4 + T cells were unable to upregulate expression of CXCR5 or Bcl-6 at day 8 after infection with LCMV ( Supplementary  Fig. 2f) . Collectively, these results demonstrated that Itch was required for the differentiation of T FH cells both at early stages and late stages and that Itch regulated T FH cell differentiation in a cellintrinsic manner.
Defective differentiation of T FH cells unrelated to T H 2 bias
Itch associates with JunB and c-Jun and promotes their ubiquitination and subsequent degradation. The increased amount of JunB protein in Itch −/− T cells drives T H 2-biased differentiation and leads to elevated production of canonical T H 2 cell cytokines, particularly IL-4 (ref. 26) . IL-4 is also one of the cytokines produced by T FH cells, especially by GC T FH cells 32, 33 , and has long been recognized as a factor involved in the survival and differentiation of B cells. However, IL-4 and its signaling pathways are not required for T FH cell differentiation 11, 34, 35 . Il4 −/− mice exhibited a frequency and number of total T FH cells and GC T FH cells similar to that of wild-type mice in 
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A r t i c l e s response to acute infection with VACV ( Fig. 3a,b) . Nevertheless, we next investigated further to confirm that the defect in T FH cell differentiation in Itch −/− mice was not due to T H 2-biased differentiation or chronic inflammation caused by overproduction of IL-4. To address this, we crossed Itch −/− mice or Itch-cKO mice with Il4 −/− mice to generate mice deficient in both Itch and IL-4 (Itch-IL-4-DKO mice). We infected the progeny with VACV and analyzed their T cell and B cell responses. We first assessed the differentiation of T FH cells in Itch-IL-4-DKO mice. The differentiation of T FH cells and GC T FH cells was considerably impaired in Itch-IL-4-DKO mice compared with that in wild-type mice (Fig. 3c,d ). The differentiation of T FH and GC T FH cells in Itch-IL-4-DKO was not greater than that in Itch −/− mice ( Fig. 3c,d) . Consistent with the reduced number of GC B cells and plasma cells in Itch −/− mice, the number of GC B cells and plasma cells in Itch-IL-4-DKO mice was also much lower than that of wildtype mice (Fig. 3e,f and Supplementary Fig. 3a) . Furthermore, the GC B cell and plasma cell responses of Itch-IL-4-DKO mice were not enhanced relative to those of Itch −/− mice (Fig. 3e,f and Supplementary Fig. 3a) , which suggested that the defect in the development of GC B cells and plasma cells in Itch −/− mice could not be 'rescued' by deletion of IL-4. Collectively, these data suggested that IL-4 did not affect T FH cell differentiation and that the defect in T FH cell differentiation in Itch −/− mice was independent of T H 2 cells.
As an additional investigation of T H 2 signaling, we next assessed whether the defective differentiation of T FH cells of Itch −/− mice could be rectified by JunB deficiency. For this, we knocked down JunB in Itch −/− and Itch +/+ (wild-type) SMARTA bone marrow through the use of short hairpin RNA (shRNA) and generated chimeras reconstituted with that bone marrow. We isolated naive SMARTA CD4 + T cells from the reconstituted mice and then adoptively transferred these cells into B6 recipient mice, followed by infection of the hosts with LCMV. Deficiency of JunB did not restore the T FH -differentiation defect of Itch −/− T cells ( Supplementary  Fig. 3b,c) . These data further confirmed that the defect in T FH cell differentiation in Itch −/− mice was independent of T H 2 cells.
IL-2 signaling is not responsible for the T FH cell defect
It has been reported that IL-2 inhibits differentiation into T FH cells 16, 17 and is in fact dose-limiting for differentiation into T H 1 cells versus T FH cells in response to an acute infection with LCMV, as twofold lower expression of the receptor for IL-2 (IL-2R) is sufficient to double the frequency of T FH cells 19 . At day 3 after infection of wild-type and Itch −/− SMARTA mice with LCMV, expression of the α-chain of IL-2R (IL-2Rα) in SMARTA Itch −/− non-T FH (T H 1) CD4 + T cells was similar to that in their wild-type counterparts ( Supplementary  Fig. 3e ). However, additional results suggested that Itch might target IL-2Rγ for ubiquitination (data not shown). We explored the possibility that the T FH -differentiation defect of Itch −/− CD4 T cells was due to enhanced IL-2 signaling. We transferred wild-type SMARTA CD4 + T cells or Itch −/− SMARTA CD4 + T cells into B6 mice that we subsequently infected with LCMV. We treated the recipient mice with neutralizing antibody to IL-2 (anti-IL-2) or isotype-matched control antibody 1 d before and 1 d after infection. Consistent with a published report 16 , neutralization of IL-2 significantly enhanced the commitment of wild-type SMARTA cells to T FH differentiation at day 3 after infection, from 17% to 36% (Fig. 4) . However, neither the frequency of T FH cells (CXCR5 + SLAM lo cells or CXCR5 + Bcl-6 hi ) nor the expression of CXCR5 and Bcl-6 protein was restored in Itch −/− CD4 T cells by neutralization of IL-2 (Fig. 4) . We also knocked down IL-2Rγ in primary SMARTA CD4 + T cells through the use of shRNA Fig. 3d,e) . Collectively, our data indicated that IL-2 signaling was probably not the key factor that led to the impaired T FH differentiation of Itch −/− cells.
'Rescue' by enforced expression of Bcl-6 As Bcl-6 has been identified as the critical transcription factor in the differentiation of T FH cells and its expression was substantially reduced in Itch −/− CD4 + T cells, we explored whether Bcl-6 is a potential target of Itch. We found that Itch associated with Bcl-6 both in vivo by coimmunoprecipitation and in vitro by precipitation assay, and we further identified a Pro-Pro-X-Tyr motif (where 'X' is any amino acid) at positions 182-185 in Bcl-6 that was responsible for the interaction ( Supplementary Fig. 4a,b) . In addition, Itch promoted both monoubiquitination and polyubiquitination of Bcl-6 ( Supplementary  Fig. 4c ). To investigate the physiological function of the modification of Bcl-6 by Itch, we transduced wild-type SMARTA CD4 + T cells with a retroviral vector expressing green fluorescent protein (GFP) alone (empty vector) or GFP and either wild-type Bcl-6 or mutant Bl-6 with replacement of phenylalanine with tyrosine, then sorted the transduced cells and transferred them into B6 recipient mice, followed by infection of the host mice with LCMV. Expression of the mutant Bcl-6 induced differentiation into T FH cells and GC T FH cells similar to that induced by wild-type Bcl-6 ( Supplementary Fig. 4d,e) . These results suggested that modification of Bcl-6 by Itch might not have an apparent physiological function in T FH cell differentiation. We then investigated whether enforced expression of Bcl-6 was able to rectify the defective T FH differentiation of Itch −/− CD4 + T cells. We transduced wild-type or Itch −/− SMARTA CD4 + T cells with retroviral vector expressing Bcl-6 or empty vector (as described above). Bcl-6 expression drove more robust T FH differentiation of wild-type SMARTA CD4 + T cells in vivo (80%) than did expression of GFP only by the empty vector (37%) 4 ( Fig. 5) . Notably, Bcl-6 expression also substantially enhanced the T FH differentiation of Itch −/− SMARTA CD4 + T cells (70% versus 6%), nearly to the extent of that of wild-type SMARTA CD4 + T cells (70% versus 80%; Fig. 5) . Furthermore, Bcl-6 expression induced similar CXCR5 expression in wild-type and Itch −/− SMARTA CD4 + T cells (Fig. 5b) . These results indicated that Itch might function mainly upstream of Bcl-6 expression and might be required for the induction of Bcl-6 expression and T FH cell differentiation.
Foxo1 as a target for Itch
We next looked for other potential targets of Itch that may be involved in regulating the differentiation of T FH cells, with a particular interest in upstream regulators of Bcl-6. Foxo proteins belong to the forkhead-box family of transcription factors, which are characterized by a conserved winged-helix DNA-binding domain called the 'forkhead' domain. Foxo transcription factors are subject to extensive and varied post-translational modifications that affect their abundance, localization and transcriptional activity, with ubiquitination being one major pathway by which Foxo factors are regulated 36 . It has been well documented that the Foxo family can be negatively regulated by the signaling pathways of phosphatidylinositol-3-OH kinase (PI(3)K) and the kinase Akt in response to insulin, growth factors or the engagement of costimulatory receptors (CD28 and ICOS) 36, 37 . Phosphorylation of Foxo factors at three conserved sites (Tyr24, Ser256 and Ser319) by the kinases Akt and SGK ('serum and glucocorticoid-induced kinase') causes their export from the nucleus and degradation and thereby prevents Foxo factors from transactivating or repressing their target genes 36 . Ubiquitination and degradation of Foxo1 can be mediated by SKP1-CUL1-F-box protein-SKP2 complex 38 . Relevant to our study here, Foxo1 has been linked to the regulation of T FH cells either in a positive manner or a negative manner 18, 39 . However, the importance of the involvement of Foxo1 or its homologs in the differentiation of T FH cells remains unclear, and the underlying molecular mechanisms by which Foxo1 is regulated in this process have not been elucidated so far. We then investigated whether Foxo1 is a substrate of Itch. Given the presence of proline-rich sequences in Foxo proteins, we assessed the ability of Itch to recognize Foxo proteins. We first coimmunoprecipitated proteins from Jurkat human T lymphocyte cells that overexpressed Foxo proteins and Itch. Only Foxo1 immunoprecipitated together with Itch, whereas Foxo3a protein did not (Fig. 6a) , which suggested that Itch selectively interacted with Foxo1. Notably, we also detected endogenous interaction between Foxo1 and Itch in purified CD4 + T cells from VACV-infected B6 mice (Fig. 6b) , which suggested that this interaction was physiologically functional. More notably, the interaction between Foxo1 and Itch in CD4 + T cell blasts was rapidly induced by restimulation with monoclonal anti-ICOS and monoclonal anti-CD3 (Fig. 6c) .
To investigate whether Itch promoted the ubiquitination of Foxo1, we transfected Jurkat T cells with plasmids expressing hemagglutinintagged ubiquitin and Myc-tagged Foxo1 (and Xpress-tagged wild-type Itch). We then either left the cells untreated or treated them with the proteasome inhibitor MG132 and then immunoprecipitated proteins from cell lysates with anti-Foxo1. Overexpression of wild-type Itch enhanced the conjugation of ubiquitin to Foxo1 in the presence of MG132 (Fig. 6d) . To assess the in vivo ubiquitination of Foxo1, we generated a new rabbit polyclonal antibody to ubiquitin and used this antibody in an assay in which we immunoprecipitated ubiquitinated protein. In these experiments, we pretreated CD4 + T cell blasts with MG132 and then restimulated them with monoclonal anti-CD3 and monoclonal anti-ICOS. After restimulation, we immunoprecipitated proteins from lysates of Itch −/− or wild-type CD4 + T cells with the polyclonal antibody to ubiquitin. We detected polyubiquitinated Foxo1 as slowly migrating, high-molecular-weight species in wild-type cells that was almost completely absent from Itch −/− cells (Fig. 6e) . Together these results suggested that Itch acted as an E3 ligase for the ubiquitination of Foxo1.
It has been reported that the PI(3)K-Akt pathway induces the phosphorylation of Foxo1 and promotes its degradation and that ICOS regulates T FH cell differentiation through the PI(3)K-Akt pathway 37, 40 . These reports prompted us to investigate whether an ICOS-PI(3)K-Akt pathway induces the degradation of Foxo1 by Itch. We examined the signal-transduction events and their consequences in ICOS-stimulated wild-type and Itch-deficient T cells. As described above, we restimulated CD4 + T cell blasts with monoclonal anti-CD3 and monoclonal anti-ICOS. Consistent with published findings 40 , engagement of ICOS substantially enhanced the activation of Akt mediated via the T cell antigen receptor, as indicated by increased phosphorylation of Akt at Ser473 in wild-type CD4 + T cells (Fig. 6f) . Phosphorylation of Foxo1 was also enhanced by ligation of ICOS in wild-type CD4 + T cells. However, phosphorylation of Akt Ser473 and 
Foxo1 ablation rectifies defective T FH cell differentiation
The expression of Foxo1 protein was much lower in T FH cells than in naive cells or non-T FH cells and was even lower in GC T FH cells (Fig. 7a) . Notably, the expression of Foxo1 mRNA was substantial in each population (Fig. 7a) , consistent with a central role for post-translational degradation in the control of Foxo1 expression. However, the expression of Itch protein and Itch mRNA was retained in all populations (Fig. 7a) . This indicated that T FH cell differentiation might require downregulation of Foxo1 expression through post-translational modification by Itch. We therefore tested mice conditionally deficient in Foxo1 or Foxo3a. The differentiation of T FH cells in response to acute infection with VACV was enhanced in Foxo1 fl/fl CD4-Cre mice compared with that of their wild-type (Foxo1 +/+ CD4-Cre or Foxo1 fl/fl ) counterparts (Supplementary Fig. 5a ). Consequently, the number of GC B cells and plasma cells was also greater in Foxo1 fl/fl CD4-Cre mice than in their wild-type counterparts after infection with VACV ( Supplementary Fig. 5b ). However, Foxo3a fl/fl CD4-Cre mice showed normal differentiation of T FH cells, as well as normal development of GC B cells and plasma cells after infection ( Supplementary  Fig. 5c,d) . These results suggested that Foxo1 was a negative regulator of the differentiation of T FH cells. We next sought to determine whether Itch affects Foxo1-mediated gene expression. We sorted wild-type and Itch −/− SMARTA CD4 + T cells from B6 recipient mice at day 3 after infection with LCMV and analyzed expression of Foxo1 targets by real-time PCR. Itch −/− cells had much higher expression of several known Foxo1 targets 41, 42 , such as Bcl2l11, Il7r, Klf2, Sell, Selplg and S1pr1, than did wild-type SMARTA CD4 + T cells (Fig. 7b) . These data suggested that Itch suppressed the expression of at least some of Foxo1 targets. . Immunoblot analysis revealed that the expression of Itch and/ or Foxo1 was almost completely eliminated in splenocytes 2 weeks after injection of the synthetic RNA duplex poly (I:C) (polyinosinepolycytidylic acid) (Supplementary Fig. 6a ). Following infection with VACV, the development of GC B cells in Itch fl/fl Mx1-Cre mice with inducible deficiency in Itch (Itch-iKO) was much lower than that in their wild-type counterparts (Fig. 7c,d and Supplementary  Fig. 6b,c) , consistent with the phenotype of Itch −/− mice and Itch-cKO mice. Likewise, the development of plasma cells was also significantly lower in Itch-iKO mice than in their wild-type counterparts (Fig. 7c,d and Supplementary Fig. 6b,c) . Unexpectedly, the development of both GC B cells and plasma cells in Itch-Foxo1-iDKO mice was increased to their development in wild-type mice (Fig. 7c,d and Supplementary Fig. 6b,c) . We next examined the differentiation of T FH cells and GC T FH cells. The frequency and absolute number of T FH cells was much lower in Itch-iKO mice than in wild-type mice (Fig. 7e,f and Supplementary Fig. 6c) . The frequency and number of GC T FH cells was also lower in Itch-iKO mice than in wild-type mice. Notably, the differentiation of T FH cells and GC T FH cells was restored in Itch-Foxo1-iDKO mice (Fig. 7e,f and Supplementary Fig. 6c) . In contrast, IL-4 production in CD4 + T cells from Itch-iKO mice was similar to that in CD4 + T cells from Itch-Foxo1-iDKO mice Fig. 6d ). These results indicated that deletion of Foxo1 did not affect Itch-mediated production of IL-4. Together these data suggested that the defect in the differentiation of GC B cells and T FH cells in Itch −/− mice could be 'rescued' by genetic ablation of Foxo1.
To investigate whether the restoration of T FH cell differentiation in Itch −/− mice via deficiency in Foxo1 was cell intrinsic, we knocked down Foxo1 expression in wild-type or Itch −/− SMARTA CD4 + T cells with a retrovirus encoding shRNA and transferred transduced and untransduced cells together into B6 recipient mice, followed by infection of the host mice with LCMV. Transduction of control shRNA (targeting CD8α) did not alter the T FH differentiation of either wildtype cells or Itch −/− cells (Supplementary Fig. 7a-c) . In contrast, transduction of shRNA targeting Foxo1 substantially enhanced the T FH differentiation of wild-type cells (Supplementary Fig. 7a-c) . Notably, knockdown of Foxo1at least partially restored the T FH differentiation of Itch −/− cells (Supplementary Fig. 7a-c) . The data further confirmed a critical role for Foxo1 in the regulation of T FH cell differentiation by Itch.
DISCUSSION
Accumulating evidence has established T FH cells as a distinct and important type of CD4 + helper T cell that has a crucial role in humoral responses to pathogen infection and damaging roles in autoimmune diseases. Bcl-6 has been identified as a master regulator of T FH cell differentiation [4] [5] [6] . However, how Bcl-6 is induced and how T FH cell differentiation is regulated still has many unknown aspects 19 . In this study, through the use of a combination of genetic, cellular and molecular approaches, we have identified a previously unknown and critical function for Itch in T FH cell differentiation and humoral immunity. We have shown that Itch was intrinsically required for both early stages and late stages of T FH cell differentiation and was associated with a substantial reduction in Bcl-6 expression. Finally, we have also shown that Itch regulated T FH cell differentiation by targeting Foxo1, a negative regulator of such differentiation, for degradation.
On the B6 background, Itch −/− mice develop chronic inflammatory diseases and constant itching of the skin 43 . Itch inhibits T H 2 differentiation by targeting JunB for ubiquitination and degradation 26 . This might all contribute to the chronic inflammatory diseases of Itch −/− mice. However, Itch −/− mice unexpectedly showed a substantial defect in T FH cell differentiation in response to viral infection. Although IL-4 is one of the cytokines produced by GC T FH cells that is required for the optimal provision of help to B cells, it has been shown that IL-4 is dispensable for T FH cell differentiation. Our data support that notion and clarify that the defective differentiation of T FH npg mice was not due to T H 2 bias, because T FH cell differentiation was also unaffected in Il4 −/− mice; the defect in the differentiation of T FH cells in Itch −/− mice was not rectified by IL-4 deficiency; and genetic ablation of Foxo1 did rectify the defect in T FH cells in Itch-deficient mice without affecting IL-4 production.
Foxo1 can be targeted for ubiquitination by several ubiquitin E3 ligases, including the SKP1-CUL1-F-box protein-SKP2 complex, MDM2, COP1 and CHIP ('C terminus of Hsc70-interacting protein'), in various cell types 44 . In this study, we identified Itch as an additional E3 ligase that targeted Foxo1 for ubiquitination and degradation. We also established that the ICOS-PI(3)K-Akt pathway led to the ubiquitination and degradation of Foxo1 by Itch. However, future studies are needed to explore details of the mechanism, including the sites modified and the polyubiquitination chain of Foxo1. In addition, the partial 'rescue' of T FH cell differentiation in the experiment in which Foxo1 was knocked down by shRNA might suggest that Itch targets other substrates. Although we found that Bcl-6 itself might be a target, the Itch-Bcl-6 association was not required for the development of T FH cells. The data reinforce the notion that Foxo1 is a critical substrate of multiple Itch targets for T FH cell differentiation. Future efforts should provide a more comprehensive understanding of the molecular interactions among the potential participants.
Emerging evidence has shown that Foxo1 and Foxo3a are involved in immunological regulation. Foxo1 and Foxo3a function redundantly as transcription factors important in the promotion of Foxp3 expression 27, 39, 45 . Although Foxo3a can bind and activate the Bcl6 promoter in B cell lymphoma lines 46 , mice with T cell-specific deficiency in Foxo3a exhibited normal T FH cell differentiation. Published studies and also our study here have shown that large numbers of T FH cells accumulate in mice with T cell-specific deficiency in Foxo1 maintained under standard housing conditions 39 or infected with a specific pathogen. However, whether this excessive formation of T FH cells is cell intrinsic or is due to loss of regulatory T cells has remained unclear 39 . A scan of the Bcl6 promoter identified Foxo-binding motifs in the DNA 18 . Although chromatin-immunoprecipitation experiments have suggested that Foxo1 binds directly to putative Foxo-binding motifs in the Bcl6 promoter 18, 42 , the consequence of such binding remains controversial. Luciferase experiments have suggested that Foxo proteins, including Foxo1, activate the Bcl6 promoter 18 . However, the in vivo data we have presented here indicated a negative role for Foxo1 in Bcl-6 expression and T FH cell differentiation. Future studies are needed to clarify this issue. In addition to Bcl6, other T FH cell-related genes, such as Cxcr4, Batf, Icos and Prdm1, have also been reported as containing Foxo1-binding sites identified by chromatin immunoprecipitation followed by deep sequencing 42 . Therefore, Foxo1 may regulate T FH cell differentiation by directly controlling the expression of T FH cell-related genes. Foxo1 can also regulate lymphocyte trafficking by inducing L-selectin and the chemokine receptor CCR7 (ref. 41) . The proposal that Foxo1 directly binds to the promoter, untranslated region, introns or intergenic regions of some genes encoding homing molecules, such as Ccr7, S1pr1, Sell and Selplg, has been further supported by chromatin immunoprecipitation followed by deep sequencing 42 . Two other studies have reported that microRNAs of the miR17~92 family regulate T FH cell differentiation by targeting the PI(3)K antagonist PTEN 47, 48 and the phosphatase PHLPP2 (ref. 48) in the ICOS-PI(3)K-Akt pathway. One of those studies also showed that the miR17~92 microRNAs are required for the ability of T FH cells to migrate to B cell follicles and GCs, although no direct mechanism was shown in that study 48 . It is reasonable to speculate that Foxo1 and Itch also regulate T FH cell differentiation at least partially through T cell migration.
In summary, our findings have established a function for Itch as a crucial regulatory factor in T FH cell differentiation. In addition, we have shown that Itch positively regulated such differentiation by promoting the conjugation of ubiquitin to Foxo1 and subsequent degradation of Foxo1. Given that published studies have shown that Itch has a negative role in regulating the differentiation of T H 2 cells and inflammatory signaling, we propose that Itch is a key participant in the control of both T H 2 cell-mediated allergic inflammation and T FH cell-promoted B cell immunity. Understanding how Itch regulates such different processes may be useful in both rational vaccine design for human infectious diseases and therapeutic intervention in human inflammatory diseases.
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